<DOC>
	<DOCNO>NCT01238640</DOCNO>
	<brief_summary>The purpose study assess bioequivalence two new oral nicotine replacement therapy product Nicorette® microtab .</brief_summary>
	<brief_title>Bioequivalence Between Two New Oral Nicotine Replacement Therapy Products Nicorette® Microtab</brief_title>
	<detailed_description>The trial single-dose , randomize , crossover design include 84 subject . The investigational product give single dos separate treatment visit . Periods without Nicotine Replacement Therapy ( NRT ) , last least 36 hour , separate treatment visit . At treatment visit , blood pharmacokinetic analysis sample immediately , 5 , 10 , 15 , 20 , 30 , 45 minute , well 1 , 1.25 , 1.5 , 2 , 3 , 4 , 6 , 8 , 10 hour start product administration . The time complete tablet dissolution record . Subjects also monitor capture adverse event may occur . Treatment label conceal subject study personnel .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Healthy subject , smoke least 10 cigarette daily least one year precede inclusion BMI 17.5 30.0 kg/m2 . Female participant childbearing potential require use medically acceptable mean birth control . A personally sign date informed consent document , indicate subject inform pertinent aspect study . Pregnancy , lactation intend pregnancy . Treatment investigational product donation loss blood within 3 month precede first dose study medication .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Smoking Cessation</keyword>
	<keyword>Nicotine</keyword>
</DOC>